Tuesday , November 21 2017
Home / Managing Editor, Diabetes in Control

Managing Editor, Diabetes in Control

Managing Editor, Diabetes in Control

Alzheimer’s Gene Linked to Diabetes

Researchers found that the Alzheimer’s gene ApoE4 could be linked to type 3 diabetes. The Apolipoprotein E (APOE) gene is one of the strongest genetic risk factors for Alzheimer’s disease. Diabetes and impaired insulin signaling in the brain are linked to the development of Alzheimer’s disease. This study shows how …

Read More »

OptiScanner

OptiScanner is the first-of-its-kind bedside blood monitoring platform that provides plasma-based, automated monitoring of ICU patients’ glucose levels. The OptiScanner 5000 directly measures plasma glucose levels using an integrated blood centrifuge and spectrometer to help avoid dangerous glycemic variations and assist clinicians in achieving the right level of glucose control.

Read More »

Bydureon BCise: A New Once-Weekly GLP-1 Agonist

The FDA has approved an auto-injector and new formulation of a once-weekly treatment for type 2 diabetes from AstraZeneca. Bydureon BCise offers a single-dose auto-injector for adults with type 2 diabetes. Bydureon BCise features a unique continuous-release microsphere technology delivery system that provides consistent levels of the product’s active ingredient, exenatide. The new formulation has shown the ability to reduce blood sugar levels alongside weight loss, despite not being a weight loss medication.

Read More »

How to Be More Culturally Sensitive

Having worked with patients, children, adolescents, and adults who have diabetes for oh so many years, I’ve learned it’s better to change what I teach than to expect my patients to change their entire lifestyle. One of the toughest things for patients to do is to change the way they eat, especially if deep rooted in their ethnic background. One example is asking patients who are from the Middle East or those who are brought up on rice and beans to avoid or cut back on rice.

Read More »